Want to see IN:ASTRAZEN full AI Analyst Report?

AstraZeneca Pharma India Limited (ASTRAZEN) Ratios

39 Followers

AstraZeneca Pharma India Limited Ratios

IN:ASTRAZEN's free cash flow for Q1 2027 was ₹0.22. For the 2027 fiscal year, IN:ASTRAZEN's free cash flow was decreased by ₹ and operating cash flow was ₹0.06. See a summary of the company’s cash flow.

Ratios	TTM	Mar 26	Mar 25	Mar 24	Mar 23
Liquidity Ratios
Current Ratio	0.00	1.77	1.91	2.61	2.18
Quick Ratio	0.00	0.73	1.13	1.97	1.68
Cash Ratio	0.00	0.46	0.76	1.42	1.30
Solvency Ratio	-0.21	0.19	0.21	0.48	0.29
Operating Cash Flow Ratio	0.00	<0.01	0.09	0.08	0.15
Short-Term Operating Cash Flow Coverage	0.00	0.49	0.00	15.40	16.56
Net Current Asset Value	₹ 8.73B	₹ 6.24B	₹ 5.95B	₹ 5.67B	₹ 4.39B
Leverage Ratios
Debt-to-Assets Ratio	0.00	0.06	0.02	<0.01	<0.01
Debt-to-Equity Ratio	0.00	0.13	0.05	<0.01	0.01
Debt-to-Capital Ratio	0.00	0.11	0.04	<0.01	0.01
Long-Term Debt-to-Capital Ratio	0.00	0.00	0.00	0.00	0.00
Financial Leverage Ratio	0.00	2.28	1.97	1.51	1.67
Debt Service Coverage Ratio	32.10	11.99	107.66	59.02	28.00
Interest Coverage Ratio	37.17	51.99	147.13	142.86	236.33
Debt to Market Cap	0.00	<0.01	0.00	<0.01	<0.01
Interest Debt Per Share	2.29	46.06	14.88	2.32	3.14
Net Debt to EBITDA	0.00	-1.18	-2.53	-2.13	-3.27
Profitability Margins
Gross Profit Margin	31.41%	26.46%	41.60%	48.03%	57.60%
EBIT Margin	9.25%	11.28%	9.21%	17.04%	13.43%
EBITDA Margin	9.96%	12.54%	11.55%	18.19%	15.05%
Operating Profit Margin	8.74%	10.26%	12.54%	13.23%	14.84%
Pretax Profit Margin	9.39%	11.08%	9.13%	16.95%	13.37%
Net Profit Margin	6.97%	8.24%	6.76%	12.47%	9.90%
Continuous Operations Profit Margin	6.97%	8.24%	6.76%	12.47%	9.90%
Net Income Per EBT	74.31%	74.35%	74.02%	73.57%	74.04%
EBT Per EBIT	107.35%	108.03%	72.79%	128.06%	90.07%
Return on Assets (ROA)	0.00%	9.43%	7.62%	14.98%	10.08%
Return on Equity (ROE)	20.29%	21.49%	15.02%	22.69%	16.87%
Return on Capital Employed (ROCE)	0.00%	23.18%	26.35%	23.78%	24.78%
Return on Invested Capital (ROIC)	0.00%	17.00%	19.36%	17.41%	18.13%
Return on Tangible Assets	0.00%	9.43%	7.63%	15.01%	10.08%
Earnings Yield	1.01%	0.97%	0.55%	1.24%	1.22%
Efficiency Ratios
Receivables Turnover	0.00	10.65	9.25	7.65	8.48
Payables Turnover	0.00	2.14	2.19	3.43	1.87
Inventory Turnover	0.00	1.63	1.82	2.95	2.24
Fixed Asset Turnover	0.00	19.37	26.95	19.98	14.29
Asset Turnover	0.00	1.14	1.13	1.20	1.02
Working Capital Turnover Ratio	6.42	3.26	2.82	2.52	2.43
Cash Conversion Cycle	0.00	87.63	73.08	64.71	10.72
Days of Sales Outstanding	0.00	34.27	39.45	47.70	43.06
Days of Inventory Outstanding	0.00	224.07	200.09	123.54	163.26
Days of Payables Outstanding	0.00	170.71	166.45	106.54	195.59
Operating Cycle	0.00	258.34	239.54	171.24	206.31
Cash Flow Ratios
Operating Cash Flow Per Share	-26.29	2.73	26.15	11.15	23.32
Free Cash Flow Per Share	-26.41	1.28	25.45	6.84	19.91
CapEx Per Share	0.12	1.44	0.70	4.30	3.41
Free Cash Flow to Operating Cash Flow	1.00	0.47	0.97	0.61	0.85
Dividend Paid and CapEx Coverage Ratio	-0.82	0.08	1.06	0.55	2.04
Capital Expenditure Coverage Ratio	-226.66	1.89	37.35	2.59	6.84
Operating Cash Flow Coverage Ratio	0.00	0.06	1.83	6.07	8.08
Operating Cash Flow to Sales Ratio	-0.03	<0.01	0.04	0.02	0.06
Free Cash Flow Yield	-0.39%	0.02%	0.30%	0.13%	0.61%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	99.04	103.53	183.43	80.50	81.90
Price-to-Sales (P/S) Ratio	6.91	8.53	12.39	10.04	8.11
Price-to-Book (P/B) Ratio	19.25	22.24	27.56	18.26	13.81
Price-to-Free Cash Flow (P/FCF) Ratio	-254.47	6.05K	333.75	759.88	163.39
Price-to-Operating Cash Flow Ratio	-255.59	2.85K	324.82	466.51	139.51
Price-to-Earnings Growth (PEG) Ratio	-13.23	1.67	-6.48	1.29	1.34
Price-to-Fair Value	19.25	22.24	27.56	18.26	13.81
Enterprise Value Multiple	69.36	66.87	104.80	53.04	50.59
Enterprise Value	168.00B	190.75B	207.30B	125.01B	76.39B
EV to EBITDA	69.36	66.87	104.80	53.04	50.59
EV to Sales	6.91	8.38	12.10	9.65	7.62
EV to Free Cash Flow	-254.47	5.94K	325.88	730.60	153.48
EV to Operating Cash Flow	-255.59	2.80K	317.16	448.53	131.05
Tangible Book Value Per Share	349.12	349.13	307.90	283.92	235.47
Shareholders’ Equity Per Share	349.12	349.13	308.16	284.77	235.48
Tax and Other Ratios
Effective Tax Rate	0.26	0.26	0.26	0.26	0.26
Revenue Per Share	972.82	910.27	685.37	518.21	401.19
Net Income Per Share	67.85	75.01	46.30	64.60	39.72
Tax Burden	0.74	0.74	0.74	0.74	0.74
Interest Burden	1.01	0.98	0.99	0.99	1.00
Research & Development to Revenue	0.00	0.00	0.00	0.06	0.00
SG&A to Revenue	0.10	0.16	0.15	0.03	0.03
Stock-Based Compensation to Revenue	<0.01	0.00	<0.01	<0.01	<0.01
Income Quality	-0.29	0.04	0.42	0.17	0.43

Currency in INR